Effective immediately, Beleave Inc.’s (BLEVF)
common shares have been approved for trading on OTCQX Market, the highest tier
of the OTC market, exclusively for U.S. and international companies that
undergo a rigorous financial and qualitative review. The company’s common
shares will trade under the ticker BLEVF.
Joining OTCQX coincides with the company’s continuing efforts to support
its existing U.S. shareholder base. U.S. investors can find current financial
disclosure and real-time Level 2 quotes for the company on the OTC website.
“We are pleased to be able to provide our current and potential U.S.
investors an improved platform to access our company’s securities,”
commented Roger Ferriera, Beleave’s chief executive officer. “We welcome
the opportunity to add to our growing investor base in the United States.”
The OTCQX Market is for established investor-focused U.S. and global
companies. To qualify for OTCQX, companies must meet high financial standards,
follow best practice corporate governance, demonstrate compliance with U.S.
securities laws and have a professional third party sponsor introduction.
Beleave will continue to trade on the Canadian Stock Exchange under its
existing symbol BE.
About Beleave Inc.
Beleave is a biotech company and Beleave’s wholly owned subsidiary Beleave
Kannabis Corp. (formerly First Access Medical Inc.) is a licensed producer
pursuant to the ACMPR (Access to Cannabis for Medical Purposes Regulations).
Beleave’s purpose-built facility is located near Hamilton, Ont.
In the interest
of full disclosure, we call the reader’s attention to the fact that
Equities.com, Inc. is compensated by the companies profiled in the Spotlight
Companies section. The purpose of these profiles is to provide awareness of
these companies to investors in the micro, small-cap and growth equity
community and should not in any way be considered as a recommendation to buy,
sell or hold these securities. Equities.com is not a registered broker dealer,
investment advisor, financial analyst, investment banker or other investment
professional. We are a publisher of original and third party news and
information. All profiles are based on information that is available to the
public. The information contained herein should not be considered to be
complete and is not guaranteed by Equities.com to be free from misstatement or
errors. The views expressed are our own and not intended to be the basis for
any investment decision. Readers are reminded to do their own due diligence
when researching any companies mentioned on this website. Always bear in mind
that investing in early-stage companies is risky and you are encouraged to only
invest an amount that you can afford to lose completely without any change in your
lifestyle. Equities has been compensated with cash, common shares and/or
warrants for market awareness services provided
.
Read Next
